Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ebi-pharm is a prominent Swiss pharmaceutical company specializing in the distribution and marketing of complementary medicine, nutrition, and health products. Founded in 1988 and based in Kirchlindach, the company acts as a key intermediary between international manufacturers and the Swiss healthcare market, including pharmacies, drugstores, and medical practitioners. Their extensive portfolio features leading brands in homeopathy, phytotherapy, and orthomolecular medicine, such as Heel and Burgerstein. Beyond distribution, ebi-pharm provides specialized services in regulatory affairs, scientific marketing, and logistics. The company is also dedicated to professional education through its ebi-forum, supporting healthcare providers with expertise in holistic health solutions. As a family-owned enterprise, ebi-pharm maintains a strong focus on quality and sustainable health management within Switzerland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ebi-pharm.